Skip to main content
. 2018 Oct 9;35(2):78–86. doi: 10.1111/phpp.12424

Figure 3.

Figure 3

Potential saved costs from avoided skin cancers 2014‐2045 in million € Cost‐savings based on the number of potential avoided cases and the discontinued average case‐costs